Back
Adaptive Biotechnologies Stock Price Chart
FREE REPORT: 2025 Gold Price Outlook
Get Your Copy of "2025 Gold Forecast: A Perfect Storm for Demand" Here.
Sell
38
ADPT
Adaptive Biotechnologies
Last Price:
$6.45
Seasonality Move:
-30.57%
7 Day Trial
ALL ACCESS PASS
$
7
2025 Gold Forecast: A Perfect Storm for Demand
Discover our Gold Price Outlook for 2025--FREE--here-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ADPT is experiencing buying pressure, which is a positive indicator for future bullish movement.
Adaptive Biotechnologies Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 6.34 | Buy |
| 20-day SMA: | 6.25 | Buy |
| 50-day SMA: | 5.54 | Buy |
| 200-day SMA: | 4.24 | Buy |
| 8-day EMA: | 6.31 | Buy |
| 20-day EMA: | 6.14 | Buy |
| 50-day EMA: | 5.69 | Buy |
| 200-day EMA: | 4.87 | Buy |
Adaptive Biotechnologies Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.23 | Buy |
| Relative Strength Index (14 RSI): | 55.98 | Buy |
| Chaikin Money Flow: | 337601 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (5.24 - 6.64) | Buy |
| Bollinger Bands (100): | (4.36 - 5.82) | Buy |
Adaptive Biotechnologies Technical Analysis
| Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Adaptive Biotechnologies Stock
Is Adaptive Biotechnologies Stock a Buy?
-
Adaptive Biotechnologies share price is 6.39 while ADPT 8-day simple moving average is 6.34, which is a Buy signal.
-
The stock price of ADPT is 6.39 while Adaptive Biotechnologies 20-day SMA is 6.25, which makes it a Buy.
-
Adaptive Biotechnologies 50-day simple moving average is 5.54 while ADPT share price is 6.39, making it a Buy technically.
-
ADPT stock price is 6.39 and Adaptive Biotechnologies 200-day simple moving average is 4.24, creating a Buy signal.
ADPT Technical Analysis vs Fundamental Analysis
Sell
38
Adaptive Biotechnologies (ADPT)
is a Sell
Is Adaptive Biotechnologies a Buy or a Sell?
-
Adaptive Biotechnologies stock is rated a SellThe current Adaptive Biotechnologies [ADPT] share price is $6.39. The Score for ADPT is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
Adaptive Biotechnologies Stock Info
Market Cap:
954.1M
Price in USD:
6.39
Share Volume:
412.6K
Adaptive Biotechnologies 52-Week Range
52-Week High:
7.07
52-Week Low:
2.28
Sell
38
Adaptive Biotechnologies (ADPT)
is a Sell
Adaptive Biotechnologies Share Price Forecast
-
What is the Adaptive Biotechnologies stock price today?The Adaptive Biotechnologies stock price is 6.39 USD today.
-
Will ADPT stock go up or go down?Adaptive Biotechnologies> share price is forecast to RISE/FALL based on technical indicators
-
Is Adaptive Biotechnologies overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Adaptive Biotechnologies is overvalued.
Is Adaptive Biotechnologies Stock a Buy?
-
Adaptive Biotechnologies share price is 6.39 while ADPT 8-day exponential moving average is 6.31, which is a Buy signal.
-
The stock price of ADPT is 6.39 while Adaptive Biotechnologies 20-day EMA is 6.14, which makes it a Buy.
-
Adaptive Biotechnologies 50-day exponential moving average is 5.69 while ADPT share price is 6.39, making it a Buy technically.
-
ADPT stock price is 6.39 and Adaptive Biotechnologies 200-day simple moving average is 4.87, creating a Buy signal.
Fundamental Analysis of Adaptive Biotechnologies
Is Adaptive Biotechnologies a good investment?
-
Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.30 per share, and an increase next year of $0.25 per share.
Technical Analysis of Adaptive Biotechnologies
Should I short Adaptive Biotechnologies stock?
-
ADPT Moving Average Covergence Divergence (MACD) indicator is 0.23, suggesting Adaptive Biotechnologies is a Buy
-
Adaptive Biotechnologies Relative Strength Index (RSI) is 55.98, which suggest Adaptive Biotechnologies is overbought
-
The Bollinger Bands (25) for Adaptive Biotechnologies is (5.24 - 6.64), which suggest Adaptive Biotechnologies is a Buy
-
The Bollinger Bands (100) for Adaptive Biotechnologies is (4.36 - 5.82), which suggest Adaptive Biotechnologies is a Buy
* Adaptive Biotechnologies stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.